Levothyroxine Sodium
- Product NDC
- 71335-1814
- 11-digit product format
- 713351814
- Labeler code
- 71335
- Product ID
- 71335-1814_09f4bc22-a7e4-481f-940b-4e5340c5ae98
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Levothyroxine Sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- NDA021342
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2020-08-03
- Substance
- LEVOTHYROXINE SODIUM
- Active strength
- 100 ug/1
- Pharmacologic classes
- Thyroxine [CS], l-Thyroxine [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
openFDA Listing Details
- Product ID
- 71335-1814_09f4bc22-a7e4-481f-940b-4e5340c5ae98
- SPL ID
- 09f4bc22-a7e4-481f-940b-4e5340c5ae98
- Product type
- HUMAN PRESCRIPTION DRUG
- Finished product
- Yes
- Brand name base
- Levothyroxine Sodium
- Generic name
- Levothyroxine Sodium
- Dosage form
- TABLET
- Route
- ORAL
- Marketing start
- 2020-08-03
- Marketing category
- NDA AUTHORIZED GENERIC
- Application number
- NDA021342
- Pharmacologic classes
- Thyroxine [CS]; l-Thyroxine [EPC]
- Listing expiration
- 2027-12-31
openFDA Active Ingredients
| Ingredient | Strength |
|---|
| LEVOTHYROXINE SODIUM | 100 ug/1 |
openFDA Harmonized Identifiers
| Field | Values |
|---|
| Unii | 9J765S329G |
| Rxcui | 892246 |
| Spl Set Id | 1aaa327d-bb10-4815-8bd3-d8c9edc6c9db |
| Manufacturer Name | Bryant Ranch Prepack |
openFDA Package Details
| Package NDC | Description | Marketing start | Sample |
|---|
| 71335-1814-0 | 1000 TABLET in 1 BOTTLE (71335-1814-0) | 2021-12-20 | No |
| 71335-1814-1 | 100 TABLET in 1 BOTTLE (71335-1814-1) | 2021-12-20 | No |
| 71335-1814-2 | 30 TABLET in 1 BOTTLE (71335-1814-2) | 2021-12-20 | No |
| 71335-1814-3 | 60 TABLET in 1 BOTTLE (71335-1814-3) | 2021-12-20 | No |
| 71335-1814-4 | 7 TABLET in 1 BOTTLE (71335-1814-4) | 2021-12-20 | No |
| 71335-1814-5 | 14 TABLET in 1 BOTTLE (71335-1814-5) | 2021-12-20 | No |
| 71335-1814-6 | 90 TABLET in 1 BOTTLE (71335-1814-6) | 2021-12-20 | No |
| 71335-1814-7 | 28 TABLET in 1 BOTTLE (71335-1814-7) | 2021-12-20 | No |
| 71335-1814-8 | 56 TABLET in 1 BOTTLE (71335-1814-8) | 2021-12-20 | No |
| 71335-1814-9 | 180 TABLET in 1 BOTTLE (71335-1814-9) | 2021-12-20 | No |
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 9J765S329G | LEVOTHYROXINE SODIUM | 6106-07-6 | LEVOTHYROXINE SODIUM |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 71335-1814-0 | 71335181400 | 1000 TABLET in 1 BOTTLE (71335-1814-0) | 1000 tablet | 2021-12-20 | No | No | Historical |
| 71335-1814-1 | 71335181401 | 100 TABLET in 1 BOTTLE (71335-1814-1) | 100 tablet | 2021-12-20 | No | No | Historical |
| 71335-1814-2 | 71335181402 | 30 TABLET in 1 BOTTLE (71335-1814-2) | 30 tablet | 2021-12-20 | No | No | Historical |
| 71335-1814-3 | 71335181403 | 60 TABLET in 1 BOTTLE (71335-1814-3) | 60 tablet | 2021-12-20 | No | No | Historical |
| 71335-1814-4 | 71335181404 | 7 TABLET in 1 BOTTLE (71335-1814-4) | 7 tablet | 2021-12-20 | No | No | Historical |
| 71335-1814-5 | 71335181405 | 14 TABLET in 1 BOTTLE (71335-1814-5) | 14 tablet | 2021-12-20 | No | No | Historical |
| 71335-1814-6 | 71335181406 | 90 TABLET in 1 BOTTLE (71335-1814-6) | 90 tablet | 2021-12-20 | No | No | Historical |
| 71335-1814-7 | 71335181407 | 28 TABLET in 1 BOTTLE (71335-1814-7) | 28 tablet | 2021-12-20 | No | No | Historical |
| 71335-1814-8 | 71335181408 | 56 TABLET in 1 BOTTLE (71335-1814-8) | 56 tablet | 2021-12-20 | No | No | Historical |
| 71335-1814-9 | 71335181409 | 180 TABLET in 1 BOTTLE (71335-1814-9) | 180 tablet | 2021-12-20 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Levothyroxine Sodium | Bryant Ranch Prepack | 2026-05-14 | HUMAN PRESCRIPTION DRUG LABEL | 103 |